MEDICLIN Aktiengesellschaft provided earnings guidance for the third quarter of 2019 and second half of 2019. The business performance to date and the outlook for the 3rd quarter, which is traditionally the strongest season in terms of sales and earnings, indicate that the Group will reach its targets for the 2019 financial year. In the second half of 2019, the Management Board expects growing sales for the Group and a significantly better Group operating result, despite rising staff costs and raw materials and consumables used.